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Ayurveda is an ancient science which is providing its 
services since ancient times. Ayurveda does not have 
only curative properties but also focus on maintaining 
constitutional balance of body. According to 
Ayurveda, health is defined as a balance of Tridosha, 
Saptadhatu and Trimalas, impairment of which results 
in unhealthy state. Most of the times and in so many 
diseases these unhealthy states are reflected  on  skin. 
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In today’s lifestyle there are so many lacunas like no 
proper Dinacharya, not having time for proper meal 
etc. people are so busy in their modern lifestyle and 
work that they don’t have a time to take care of their 
skin and health. We all are moving far away from 
nature because of urbanization due to which ratio of 
all the diseases are increasing rapidly. Skin diseases 
are prime among them because it compel persons to 
lead a miserable life due to stress caused by ugly 
external appearance. It gives a lot of psychological 
disturbances. Smooth and glowing complexion of the 
face increases the beauty of a person and also gives 
self-confidence. In Ayurveda, Acharya Sushruta was 
first to explain about disease called Vyanga under 
Kshudra  Roga.[1] Vyanga is a disease which directly 
affects the beauty face which is mainly caused by 
mental stress conditions.[2] Acharya Vagbhata has 
explained that because of Krodha, Shoka, Ayasa, Vata 
and Pitta Dosha gets vitiated and takes 
Sthansamshraya at Mukhgata Twacha and cause 
Dushti of Bhrajak Pitta due to which painless, thin, 
A B S T R A C T  
In Ayurveda Vyanga is a disease which is firstly described by Acharya Sushruta  under Kshudra  Roga. 
According to Acharya Sushruta  Krodha and Shoka are responsible for development of Vyanga, as 
these psychological factors vitiate Pitta and Vata Dosha which then travel and get localized on facial 
skin and leads to development of Nirujam, Tanu Shyava Varna Mandala. Ayurveda is very effective in 
treating skin disorders and skin is also mentioned as a route of drug administration in terms of 
Bahiparimarajan Chikitsa. Acharya Sharangdhara has mentioned various Lepa formulations for various 
skin diseases; among them he has quoted Arjuna Twak  Churna  and Manjishtha Churna  for 
treatment of Vyanga. It is easy to understand about Manjishtha because it is a very well known 
established Varnya  drug, but regarding Arjuna it was very much important to trail it clinically as it is 
an established drug for heart. From Dravyaguna point of view it was very important to study Arjuna, 
that how it would have broken the pathogenesis of Vyanga, what are the major chemicals present in 
Arjuna that work on hyper pigmentation. So a proper revalidation of Shastrokta quote of Acharya 
Sharangdhara was done by clinical trial and pharmacognostical and HPTLC analysis of Arjuna and 
Manjishtha. 
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Shyava Varna Mandalas get develop along with 
symptoms of Daha and Kandu.[4] Though it is not a 
serious systemic disease but has great importance in 
society. Vyanga is not painful for body but is very 
much painful for mind; therefore treating Vyanga has 
become a major problem. Lepa was selected for 
management of Vyanga to make treatment simple, 
effective and convenient to patients. According to 
classics various Lepa are advised in various facial 
problems. So, on the basis of reference given by 
Acharya Sharangdhara,[3] Arjunatwak Churna  and 
Manjishtha Churna  were selected to provide effective 
and safe medicine to society. 
AIMS AND OBJECTIVES 
1. To evaluate the efficacy of Arjuna Twak  on 
Vyanga in comparison to Manjishtha.  
2. To observe the Pharmacognostic, Phytochemical 
and Pharmacological study of Arjuna Twak  and 
Manjishtha. 
3. To find out the safe, effective, low-cost, easily 
available drug for the patient suffering from 
Vyanga. 
MATERIALS AND METHODS 
Patients: For the clinical study patients of Vyanga 
were taken randomly from the OPD section of 
Kayachikitsa Department of Pt. Khushilal Sharma 
Govt. (Autonomous) Ayurveda College and Institute, 
Bhopal (M.P). 
Drugs: The raw drug Arjuna and Manjishtha was 
obtained from the Pharmacy of Pt. Khushilal Sharma 
Govt. (Autonomous) Ayurveda College and prepared 
at Rasashastra Department of College.  
PHARMACOGNOSTICAL STUDY 
The Terminalia Arjuna bark and Rubia cordifoila stem 
and their powder had been used for macroscopic and 
microscopic study. This was evaluated and 
photographed by leica DM 3000 Microscopic in 10X, 
20X, 40X with the help of Vindhya Herbal Testing and 
Research Laboratory, Van Parisar, Barkheda Pathani, 
Bhopal, (M.P.) India. 
ANALYSIS RESULTS 
Organoleptic Characters 
SN  Test 
parameters 
Results of Arjuna  Results of 
Manjishtha  
1. Condition  Dried  Dried  




3. Odour  Indistinct  Characteristic  
4. Taste  Bitter  Indistinct  
 
Figure 1: T.S. section of Arjuna bark 
 
Figure 2: T.S. section of Manjishtha stem 
 
Phytochemical Analysis 
The analytical study of Arjuna bark and Manjishtha 
was undertaken to analyze the sample by using 
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Nil  Not more 
than 2% 




4.65% Not more 
than 12% 










0.72% Not more 
than 1% 



















30.03% Not less 
than 17% 
 
Figure 3: Rf value spots of Arjuna 
 
Figure 4: HTLC plate of Arjuna 
 
Study design 
The study was conducted on total 60 patients and all 
patients completed their treatment. It was a 
randomized control trial study of Arjuna in compared 
to Manjishtha on Vyanga. A complete proforma 
included all history taking points, criteria and 
investigations and written consent was taken from all 
the patients before trail. 
Administration of drug with duration 
SN Title  Group A Group B 
1. Name of Drug       Arjuna Twak 
Churna  
Manjishtha 
Churna   
2. Applicable mode Lepa Lepa 
3. Base Navneeta Navneeta 






5. Duration  8 weeks 8 weeks 
6. Follow-up 15 days 15 days 
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Intercession 
▪ All the patients were assessed before and after 
clinical trial. 
▪ Written consent was taken from every patient. 
▪ All the details regarding study was explained to 
every patient and was set free during the study. 
Diagnostic criteria 
Patients characterized with 
Niruja (painless), Shyava (bluish black), Tanu 
Mandalas (macules) on the face, Skin appearing rough 
with bluish black patches / spots, If edges are coppery 
red or white, Itching, Burning sensation with tingling. 
Inclusive criteria 
Patients fulfilling the diagnostic criteria, between the 
age group 16 and 60 years, irrespective of sex, 
religion, occupation, and chronicity were selected for 
the study. 
Exclusion criteria 
Hyperpigmentation caused due to any systemic 
diseases such as; 
▪ Addison's disease, 
▪ Cushing syndrome and  
▪ Systemic lupus erythematosus,  
▪ Hyperpigmentation since birth like nevus and 
▪ Those caused by tumors such as malignant 
melanoma 
Effect of Therapy on Cardinal Symptoms 
Symptom  Group A % Group B % 
Itching on patch 58.9 58.6 
Burning on patch 62.1 54.1 
Dryness  52.17 59.75 




Number of lesion 64.6 66.66 
Size of lesion  66.06 67.10 





DISCUSSION ON EFFECT OF THERAPY 
Itching: Itching is caused by vitiated Kapha and Arjuna 
and Manjishtha both possess Kashaya Rasa and 
Ruksha Guna, by which they subsides the vitiated 
Dosha and relief in symptom is obtained. 
Burning: Vyanga is Pitta Pradhan Vyadhi and burning 
is a main symptom of vitiated Pitta. Arjuna possesses 
Sheeta Veerya by which it could have subsided effect 
of vitiated Dosha whereas Manjishtha possess 
Madhura, Tikta, Kashaya Rasa which all are Pitta 
Shamaka. According to Acharya Sushruta  Veerya is 
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this basis that Arjuna is more effective than 
Manjishtha on this symptom. 
Dryness: Dryness in Vyanga is caused by vitiated Vata. 
Manjishtha shows better results in dryness as it 
possess Guru Guna, Madhura Rasa and Ushna Veerya. 
All these inherent properties subsides vitiated Vata. 
Oiliness: Oiliness is caused by vitiated Kapha and 
Arjuna possesses Kashaya Rasa which prominently 
controls oil, whereas Manjishtha is also Kashaya in 
Rasa.  
Skin lusture (Shyava Varna): Shyava Varna occurs 
because of Dushti of Bhrajak Pitta caused by vitiated 
Vata. Sheet Veerya of Arjuna and Guru Guna of 
Manjishtha pacify vitiated Dosha and corrects 
Vaivarnyata. 
Number and size of lesion: In both parameters Arjuna 
shows improvement with mean percentage of 65.33 
and Manjishtha shows improvement with mean 
percentage of 66.88. 
During study it was observed that results of 
Manjishtha were markedly visible within a week after 
trail started, whereas Arjuna took near about 20-25 
days to make results visible. The whole study was of 8 
weeks and in patients of Manjishtha group after 
completing a month, results started getting stagnate 
but a continuous progressive results were seen in 
patients of Arjuna group. 
Probable mechanism of Lepa 
As Vyanga is Pitta Pradhana Vyadhi, so the amount of 
Sneha i.e. base was 1/6th part of Churna  and thickness 
advised to apply was of ½ Anguli (as described by 
Acharya Sharangdhara of Varnya  Lepa). 
Application of Lepa should be done opposite hair 
follicles due to which active principle of Lepa gets 
absorbs through hair follicle and absorption forwards 
through sweat vessles and capillaries and works on 
affected area. 
Mode of action of drug on hyperpigmentation from 
modern point of view 
Before understanding the mode of action of drug it is 
important to know, concept of pigmentation, 
mechanism of drug action, potential of plant 
phenolics in hyper pigmentation. 
1. Concept of pigmentation: The primary 
determinant of variability in human skin colour is 
the density, amount as well as the distribution of 
melanin pigment secreted by melanocytes cells in 
the basal layer of the epidermis by a process 
known as melanogenesis.[5] 




Individuals with darker skin tone have mostly 
eumelanin as compared to pheomelanin and vice-
versa.[6] Various physiological processes determine 
pigmentation in human body, few of which are 
controlled genetically. 
Function of skin lightening agents - Skin lightening 
agents interfere in the,[7] 
▪ Melanogenesis pathway or, Melanin transfer or, 
Desquamation of lowering pigmentation on the 
surface of skin, which, generally acts by any of the 
ways such as,[8] 
▪ Tyrosinase inhibition, 
▪ Mitf ( micropthalmia - associated transcription 
factor) inhibition, 
▪ Down regulation of MC1R ( melanocortin 
receptor1 which is Gs- protein- coupled- receptor) 
activity, 
▪ Interference with melanosome maturation and 
transfer and melanocyte loss.  
2. Mechanism of drug action9: Drugs (except those 
gene based) do not impart new functions to any 
system, organ or cell; they only alter the pace of 
ongoing activity. The basic types of drug action 
can be broadly classed as: 
Stimulation, Depression, Irritation, Replacement, 
Cytotoxic action 
Majority of drugs produce their effects by interacting 
with discrete target biomolecule, which usually is a 
protein. Such mechanism confers selectivity of action 
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to drug. Functional proteins that are targets of drug 
action can be grouped into four major categories, viz. 
Enzymes, Ion channels, Transporters, Receptors 
▪ Enzymes:  Enzymes are very important target of 
drug action. Drugs can either increase or decrease 
the rate of enzymatically medicated reactions. 
▪ Enzyme inhibition10: Some chemicals (heavy 
metal salts, strong acids and alkalies, 
formaldehyde, phenol etc.)  denature proteins 
and inhibit all enzymes non selectively. They have 
limited medicinal value restricted to external 
application only. However, selective inhibition of a 
particular enzyme is a common mode of drug 
action. 
Hence by this we can understand that the drug of this 
study has worked on mechanism of enzyme inhibition 
as tyrosinase also known as polyphenol oxidase is a 
copper containing enzyme present in melanocytes 
that catalyzes two major reactions during 
melanogenesis, including hydroxylation of tyrosine 
and oxidation of the o- diphenyl product, L-DOPA 
which produces a highly reactive intermediate that is 
further oxidized to form melanin by free-radical- 
coupling pathway.  
3. Potential of chemicals of Arjuna in 
hyperpgmentation 
Aqueous extract of T. Arjuna bark was analysed for its 
composition and molecular weight distribution by 
dialysis. Compositional analysis revealed that it has 
44% polyphenols and dialysis study showed that 70% 
of polyphenols have molecular weight greater that 
3.5kDa. HPTLC confirmed that it contains flavon-3-ols 
such as (+)- catechin, (+)- gallocatechin and (-)- 
epigallocatechin. 
Phenolic acids such as gallic acid, ellagic acid and its 
derivatives are also found in T. Arjuna extract. 
Triterpine glucosides are arjunetin, arjunoglucoside 1, 
arjunoglucoside 2, arjunoglucoside 3, arjunocide 1 
and 2. Polyphenols are arjunin, arjunone and 
arjunotone. 
▪ Gallic acid -  A research study was carried out on 
action of gallic acid on tyrosinase inhibition. In this 
study the effect of Gallic acid on mushroom 
tyrosinase, tyrosinase inhibitory activity and 
melanin content were assessed in B16 melanoma 
cells. results indicated that gallic acid exerts 
antimelanogenic activity coupled with antioxidant 
properties by suppressing RS (reactive species) 
generation.[11] 
▪ Ellagic acid - A research study conducted on 
ellagic acid on hyperpigmentation caused by UV 
rays. In this study conclusion was that, Ellagic acid 
is oxidized by tyrosinase, producing reactive o-
quinones. Furthermore, ellagic acid which is a 
powerful antioxidant, chemically reduce the o-
quinones (o- dopaquinone) and semiquinones, in 
this way inhibiting the melanogenesis.[12] 
▪ Tannin - A research study was carried out on 
tannin as tyrosinase inhibitor in which results 
indicated that tannins were potent tyrosinase 
inhibitors. Results indicated that tannins were 
reversible and mixed type inhibitors. Fluroscence 
quenching, copper interacting, and molecular 
docking techniques were used to unravel the 
molecular mechanism of inhibition. The results 
showed that the hydroxyl group on the B ring of 
tannin could chelate the dicopper ions of the 
enzyme.[13] 
▪ Catechins - A research was carried out on 
depigmenting effect of catechins. In this study (-) 
epigallocatechin-3-gallate (EGCG), (-) - 
epigallocatechin (EGC), (-) catechin (c), and gallic 
acid (GA) were used. The catechin group inhibited 
melanin synthesis in B16 melanoma cells. To 
elucidate the anti-melanogenic mechanism of 
catechin group, western blotting analysis was 
adopted for crucial melanogenesis protein name 
tyrosinase. The result indicated that catechin 
group has anti-melanogenic activity and might be 
effective  in hyperpigmentation disorders.[14] 
Mode of action of Manjishtha - Chemically, it 
contains glucoside known as manjishthin and 
pupurine, along with resins, lime salts and colouring 
agent which directly acts on melanin pigment.[15] 
Methanolic extract of this herb has been reported to 
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show 14.80% mean inhibition of tyrosinase activity 
thereby acting as a skin whitening agent.[16] 
CONCLUSION 
Vayanga is a disease which is defined firstly by 
Acharya Sushruta  under Kshudra Roga and in today’s 
context it can be correlated with melasma on the 
basis of pattern of hyperpigmentation and other sign 
and symptoms. The trial drug Arjuna is widely 
accepted as a herbal hero of heart and its 
effectiveness in Vyanga has proved its versatility. 
Vyanga is a disease which is mainly caused by 
pshycological factors Krodha, Shoka, Ayasa and other 
etiological factors like Pitta Pradhan Ahara Vihara and 
in modern context mealsma is caused by hormonal 
changes and sun exposure. Because of stress neurons 
in hypothalamus secretes corticotrophin release 
hormone which is transported to pituitary glands 
where it binds with CRH1 receptor (receptor of 
melanocytes), which stimulates the function of 
melanocyte cells and increase melanin formation. In 
Ayurveda Lepa is advised to apply opposite hair 
follicles, the reason behind this may be that it allows 
the active principle of medicine to absorb through 
follicles and move forwards through capillaries and 
sweat vessels and works on affected area. In modern 
also the medicines of local application works on 
mechanism of enzyme inhibition and tyrosinase which 
is released from melanocyte cells and is responsible 
for melanin formation is also a copper containing 
enzyme. Arjuna inherits Kashaya Rasa and Sheeta 
Veerya by which it subsides all the symptoms of 
Vyanga i.e. Daha, Kandu, Shyava Varna. Gallic acid, 
tannins, catechin group inhibits tyrosinase activity by 
which excess formation of melanin gets control and 
reduction in hyperpigmenation is seen. Ellagic acid 
works on reactive agents i.e. quinines and reduce the 
formation of melanin. Whereas the colouring agents 
and main chemical of Manjishtha i.e. manjishthin and 
purpurin works directly on melanin pigment. 
Therefore its results are quickly visible but are 
stagnate after a fixed period of time, but Arjuna works 
on root of chain of melanin formation therefore 
visibility of results are quite slow but is very effective 
and progressive. And it can be used for long term. In 
result of subjective parameters group A showed relief 
of 57.78% wheras group B showed relief of 53.65%. In 
results of objective parameter group A showed relief 
of 65.33% and group B showed relief of 66.88% 
whereas in overall assessment the relief percentage of 
group A was 59.94% and in group B it was of 57.43%. 
Majority of the patients showed moderate results. As 
in this study single drug therapy in form of local 
application was used and results are moderate so 
there is a possibility that if along with this local 
application proper line of treatment with oral 
medication will be followed than better results could 
come out. In form of Arjuna Twak  we have found a 
very effective easily available and low cost drug for 
Vyanga. Though Vyanga is not a serious systemic 
disease but possess equal importance because of its 
psychological effect on life. We accept it or not but 
somehow external beauty possess a great importance 
in everyone’s life. So Arjuna could be a drug  of choice 
for treating Vyanga. 
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